formed under general anaesthesia with spontaneous or controlled ventilation, based mostly on anaesthetists' preference. Besides hypoxaemia, the most commonly observed adverse event (AE) for rigid bronchoscopy is barotrauma, a severe AE associated with ventilation control. 4 5 However, Zhang and colleagues 6 reported that the rate of occurrence of a pneumothorax is 2.31% in children with preoperative respiratory impairment. Considering the advantages of spontaneous ventilation (better ventilation/perfusion, V/Q, ratio during general anaesthesia, 7 guaranteed adequate anaesthesia depth, 8 and absence of barotrauma), spontaneous ventilation techniques are appropriate for airway FB removal in children with preoperative respiratory impairment. Because of their pharmacological properties, the combination of propofol and remifentanil confers particular value for airway endoscopy in spontaneously breathing adult and paediatric patients. 9 -12 However, spontaneous breathing may be difficult to maintain with remifentanil, and significant hypercarbia may occur. 13 Previous studies have demonstrated that dexmedetomidine offers an ideal condition for rigid bronchoscopy by producing obtunded airway reflexes and stable haemodynamic and respiratory profiles in spontaneously ventilating children. 14 15 Based on these findings, we hypothesized perioperative respiratory profile for FB removal in children than remifentanil/propofol (RP)-TIVA with spontaneous ventilation. , and allergy to local anaesthesia were excluded from the study. An experienced surgeon and anaesthetist who had performed at least 50 previous FB removal cases participated in this study. Patients fasted for 6 h and no premedication was given. On arrival in the operating theatre, patients were randomly (computer-generated) assigned to receive either DP-TIVA (n¼39) or RP-TIVA (n¼38). Volatile induction with sevoflurane was performed and anaesthetic maintenance was switched to TIVA as soon as i.v. access was obtained. Propofol infusion was set at a constant rate of 200 mg kg 21 min 21 .
Methods
In Group DP, dexmedetomidine was administered i. and glottic structures, and into the trachea via a direct laryngoscope. If there was no reflex response from the patient within 2 min after lidocaine application, airway instrumentation was begun, and 100% oxygen was administered via a side arm of the rigid bronchoscope (Karl-Storz, Tuttlingen, Germany). Baseline heart rate (HR), mean arterial pressure (MAP), respiratory rates, and pulse oxygen saturation (Sp O 2 ) were recorded before induction (T 0 ). HR, MAP, and respiratory rate were monitored at the following time points: during laryngoscopy when lidocaine was sprayed (T laryn ), during insertion of the rigid bronchoscope (T bron ), 5 min after the start of the procedure (T 5 ), during extubation of the rigid bronchoscope at the end of the procedure (T end ), 5 min after the discontinuation of anaesthetics (T +5 ), and at the time of discharge from the postanaesthesia care unit (PACU) (T dis ). Because it was difficult to record the end-tidal CO 2 . Patients were transferred on their lateral side to the PACU for recovery. Once children reached a modified Aldrete score 16 .10, they were transferred back to the ward. Induction time was defined as the time from volatile induction to the insertion of the rigid bronchoscope. Recovery time was defined as the time from anaesthesia discontinuation to PACU discharge. Patients were monitored for an additional 6 h after returning to the ward. Only those who developed desaturation and dyspnoea received an emergency X-ray. All patients with successful FB removal routinely received a postoperative X-ray on the following day. If the X-ray was negative, the patient was discharged. Patients with failed FB-removal due to non-organic FB stuck in the bronchioles were transferred to a nearby hospital for thoracotomy. In patients who failed FB removal with an organic FB located in a further lobe, antibiotics were administered for 2 -3 days and another rigid bronchoscopy was attempted.
Ryu and colleagues 17 reported 29% desaturation in patients with RP anaesthesia and 3% desaturation in patients with DP during flexible bronchoscopy. We used previously detailed power analyses, 17 taking into account expected standard deviations, to estimate that a sample of at least 38 patients would be required to detect a significant difference between the two groups at the level of 0.05 with a power of 0.8. Desaturation rates were our primary outcome parameter, and all other measured parameters were considered secondary outcome parameters. Data are reported as mean (SD), unless otherwise noted. Parametric data were analysed with an unpaired Student's t-test. Ordinal data were analysed using the Mann -Whitney ranked-sum test. Nominal data were analysed using either x 2 or Fisher's exact test. Interaction between time and group factors in a two-way analysis of variance (ANOVA) with repeated measurements was used to analyse differences of respiratory and haemodynamic profiles (i.e. HR, MAP, respiratory rate, and E ′ CO 2 ) between patients in Group DP and in Group RP. The post hoc Bonferroni test was used to compare differences in respiratory and haemodynamic variables between the two groups at different time points. P-values of ,0.05 were considered significant.
Results
Seventy-seven paediatric patients were enrolled [Group DP (n¼39), Group RP (n¼38)] and completed the study (Fig. 1) . One child in Group DP and two children in Group RP were excluded from the study because of neuromuscular blocking agent use. Clinical characteristics of the two groups of children are shown in Table 1 . Distribution of age, gender, weight, duration of FB, and type of FB were not significantly different between the two groups.
During the procedure, none of the patients presented with severe breath-holding, body movement, or progressive hypoxaemia. Induction times, anaesthesia durations, maximal remifentanil administration rate, AEs, and recovery times are listed in Table 2 .
Regarding haemodynamic variables, DP and RP both slowed HR and decreased MAP. Repeated-measurement ANOVA with a post hoc Bonferroni test showed a difference in HR over times between the two groups, with HR at T 5 , T end , T +5 ,T +10 , and T dis being significantly lower in Group DP than in Group RP ( Fig. 2A, P¼0 .0002). Bradycardia (HR , 60 beats min 21 ) was seen in two children during DP induction and atropine 0.01 mg kg 21 was given. There was a significantly increased MAP in the DP vs RP group over time (Fig. 2B, P¼0 .0025, two-way ANOVA with repeated measurement). The post hoc Bonferroni test showed that children who received DP had a higher MAP at T lary , T bron , T 5 , T end , T +5 , and T +10 than those who received RP. The respiratory rate and E ′ CO 2 at different time points in the two groups are shown in Figure 3 . In Group RP, the respiratory rate was maintained at 50% reduction in the baseline value during the procedure (Fig. 3A) and resulted in a high mean Seventy-seven children were randomized; three children (one from Group DP, two from Group RP) were excluded due to neuromuscular blocking agent use. DP, dexmedetomidine/propofol group; RP, remifentanil/propofol group. (6.8 kPa) at the end of the procedure (Fig. 3B) . In Group DP, the respiratory rate was approximately maintained at the baseline level during the procedure and correlated with a normal mean E ′ CO 2 (5.8 kPa) at the end of the procedure. Once anaesthetics were discontinued, respiratory rate increased and E ′ CO 2 decreased rapidly, with both parameters returning to normal levels, in both patient groups, within 5 min.
In the PACU, 21 RP group patients (55.3%) coughed without treatment, and only four DP group children (10.3%) experienced coughing (P,0.0001). No desaturation was observed in any patient while recovering on 40% oxygen. No laryngospasm, pneumothorax, or arrhythmias were observed in any patient. Time to emergence (Table 2 ) was significantly longer in Group DP (65.1 min) than in Group RP (23.8 min; P,0.0001). Repeated-measurement ANOVA shows significant difference in HR over times between the DP group and the RP group, with HR at T 5 , T end , T +10 , and T dis lower in Group DP than in Group RP. There was a significantly increased MAP in the DP vs RP groups over time. T 0 , baseline value before anaesthesia; T laryn , at insertion of a laryngoscope; T bron , at insertion of a rigid bronchoscope; T 5 , 5 min after the start of the procedure; T end , at the end of the procedure; T +5 and T +10 , 5 and 10 min after the procedure, respectively; T dis , at discharge from the PACU. *P,0.05, ** P,0.01, ***P,0.001. over times between the DP group and the RP group. Respiratory rate was significantly lower at T laryn, T bron , T 5 , T end , and T +5 in Group RP than in Group DP. End-tidal CO 2 was higher at T end in Group RP. T 0 , baseline value before anaesthesia; T laryn , at insertion of a laryngoscope; T bron , at insertion of a rigid bronchoscope; T 5 , 5 min after the start of the procedure; T end , at the end of the procedure; T +5 and T +10 , 5 and 10 min after the procedure, respectively; T dis , at discharge from the PACU. *P,0.05, ** P,0.01, ***P,0.001.
Discussion
We compared DP-TIVA with RP-TIVA in terms of haemodynamic and respiratory profiles, AEs, and recovery time for airway FB removal in spontaneously breathing children. DP-TIVA provided more stable respiratory and haemodynamic profiles that RP-TIVA, but significantly prolonged recovery time.
Rigid bronchoscopy for airway FB removal is a brief but intense procedure that demands special anaesthesia management, including unhindered airway access for the surgeons, adequate oxygenation and gas exchange to avoid hypoxaemia, and stabilized haemodynamics. Spontaneous ventilation provides better V/Q matching, effective alveolar ventilation, 7 and no barotrauma. Volatile induction/maintenance anaesthesia for airway FB removal reportedly stabilizes respiration, HR, and MAP, 18 but causes significant environmental pollution. Combination of RP-TIVA in spontaneously breathing children is an alternative approach, but may cause respiratory depression leading to hypercarbia or apnoea. 13 Because of these limitations, another option that provides FB surgery-specific airway access while preserving optimal respiration is beneficial.
Dexmedetomidine uniquely provides analgesia without causing respiratory depression. 19 20 We observed similar desaturation, bucking, and light breath-holding rates in the DP and RP groups, suggesting that DP-TIVA relieves intratracheal procedure stimuli as effectively as RP-TIVA. The DP group respiratory profile was stable, respiratory rate was maintained at baseline levels during the procedure, and the E ′ CO 2 was normal at T end , indicating that dexmedetomidine did not impair respiratory drive. The RP group respiratory rate decreased to half of the baseline value throughout anaesthetic maintenance, resulting in hypercarbia at T end . Although respiratory rate and E ′ CO 2 returned to the baseline level quickly after anaesthesia discontinuation, caution is required when administering RP-TIVA to patients with a before operation-compromised respiratory drive, to prevent excessive respiratory depression. Consistent with our previous study, 21 HR and MAP decreased but MAP maintained a mean value .50 mm Hg in Group RP during the procedure. Two DP group children aged .40 months received atropine 0.01mg kg 21 to treat bradycardia during induction. Our findings are consistent with reported tolerance of dexmedetomidine in children, 14 15 22 suggesting that DP is effective and without clinically significant AEs when used for paediatric airway FB removal. High-dose dexmedetomidine causes peripheral vasoconstriction and increased systolic arterial pressure in adults. 23 In our study, DP lowered HR, but increased MAP, vs RP-TIVA. In the PACU, 55.3% of RP patients coughed, a sign of airway reflex return, while only 10.3% of DP children coughed. Recovery time was also significantly shorter in Groups RP vs DP (23.8 vs 65.1 min, respectively). Prolonged emergence and decreased coughing with DP may reflect the longer elimination t 1/2 of dexmedetomidine (2 h) vs remifentanil (5 min).
Our study has limitations. First, the anaesthetist was not blinded to drug assignment. Secondly, because of large interindividual variation in respiratory depressant responses, individualized dose titration was necessary. 24 Authors' contributions K.C. is the first author for this article and contributed to all aspects of this study. M.Y. and C.-B.H. made substantial contributions to the conception and design of the study, data collection and explanation, and manuscript writing. X.S. is the corresponding author for this study, designed the study, and performed draft revisions. All authors have approved the current manuscript to be released for publication.
